INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Option exerciseVerified data

Hariri Robert J reported CELU

Director, Chief Executive Officer · Celularity Inc · Celularity Inc — Restricted Stock Units

Side
M
Value
—
Shares
3,281
Price
—
Executed
Apr 13, 2026
Disclosed
Apr 15, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 13 executedApr 15, 2026 disclosed

CELU · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CELU

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    BS
    Brigido StephenPres., Functional Regeneration
    CELUCelularity Inc
    Option exercise
    		M—
    821 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HJ
    Hariri Robert JDirector, Chief Executive Officer
    CELUCelularity Inc
    Option exercise
    		M—
    3,281 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HJ
    Hariri Robert JDirector, Chief Executive Officer
    CELUCelularity Inc
    Tax withholding
    		F$1,513
    1,182 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    HR
    Haines John RSenior Exec Vice President
    CELUCelularity Inc
    Option exercise
    		M—
    1,641 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HR
    Haines John RSenior Exec Vice President
    CELUCelularity Inc
    Tax withholding
    		F$746
    583 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HR
    Haines John RSenior Exec Vice President
    CELUCelularity Inc
    Option exercise
    		M—
    1,641 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    BS
    Brigido StephenPres., Functional Regeneration
    CELUCelularity Inc
    Option exercise
    		M—
    821 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BS
    Brigido StephenPres., Functional Regeneration
    CELUCelularity Inc
    Tax withholding
    		F$343
    268 sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    LD
    Ling Geoffrey M.D.Director
    CELUCelularity Inc
    Grant or award
    		A—
    19.2K sh
    		Jan 12, 2026Jan 14, 2026
    traded Jan 12, 2026
    		+2dSEC FORM 4

    Evidence

    17
    LV
    LeVien VincentDirector
    CELUCelularity Inc
    Grant or award
    		A—
    28.8K sh
    		Jan 12, 2026Jan 14, 2026
    traded Jan 12, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001493152-26-016832
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 13, 2026
    Published
    Apr 15, 2026
    Ingested by INSIDER
    Nov 5, 04:04 UTC
    Last re-read
    Nov 5, 04:04 UTC

    Extracted facts

    Filer
    Hariri Robert J
    Role
    Director, Chief Executive Officer
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Celularity Inc — Restricted Stock Units
    Ticker
    CELU
    Shares
    3,281
    Price per share
    $0
    Execution date (reported)
    Apr 13, 2026
    Owned after transaction
    0 shares
    Days from execution to publication
    2

    What this establishes

    Hariri Robert J filed this Form 4 reporting a option exercise of CELU on Apr 13, 2026. It became public on Apr 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, Chief Executive Officer
    Hariri Robert Jcik:0001398815
    Issuer
    Celularity Inccik:0001752828

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.